LanzaTech Announces Fourth-Quarter and Full-Year 2024 Financial Results
Written by Emily J. Thompson, Senior Investment Analyst
Source: Newsfilter
Financial Performance Overview: LanzaTech reported a significant decline in revenue for both the fourth quarter ($12.0 million) and full year 2024 ($49.6 million), compared to $20.5 million and $62.6 million in 2023, primarily due to project completions and timing delays in large biorefining projects.
Operational Focus and Challenges: The company is shifting its focus from research and development to global deployment of its technology while exploring liquidity-enhancing initiatives; however, management has expressed concerns about the company's ability to continue as a going concern under GAAP requirements.
Analyst Views on LNZAW
Wall Street analysts forecast LNZAW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LNZAW is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 0.014
Low
Averages
High
Current: 0.014
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
